Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

UBS Upgrades ZoomInfo Technologies to Buy

UBS analyst Taylor McGinnis upgrades ZoomInfo Technologies (NASDAQ:ZI) from Neutral to Buy.

byBenzinga Newsdesk

November 2, 2021

1 minute read

UBS analyst Taylor McGinnis upgrades ZoomInfo Technologies (NASDAQ:ZI) from Neutral to Buy.

Benzinga Launches NFT Madness 2022 Tournament: A Bracket Of 64 Top NFTs Projects Competing For The Championship

By Chris Katje

March 22, 6:20 PM

To coincide with the NCAA Men’s Basketball Tournament, Benzinga launched an NFT Madness 2022 Tournament with 64 NFT collections competing for the championship.

$AVAX

Raymond James Maintains Outperform on Flywire, Raises Price Target to $48

By Benzinga Newsdesk

August 11, 7:28 AM

Raymond James analyst John Davis maintains Flywire (NASDAQ:FLYW) with a Outperform and raises the price target from $39 to $48.

FLYW

News
Rumors

Southwest Air Shares Quiet Following Info From Air Flight Tracker, Flightaware, Co. Has 14% Of Flights Cancelled, 15% Delayed

By Benzinga Newsdesk

June 15, 2:13 PM

-Bloomberg

LUV

Morgan Stanley Maintains Equal-Weight on Arrowhead Pharmaceuticals, Lowers Price Target to $37

By Benzinga Newsdesk

November 29, 8:38 AM

Morgan Stanley analyst Andrew Galler maintains Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Equal-Weight and lowers the price target from $41 to $37.

ARWR

UBS Upgrades ZoomInfo Technologies to Buy

Related Posts

Benzinga Launches NFT Madness 2022 Tournament: A Bracket Of 64 Top NFTs Projects Competing For The Championship

Raymond James Maintains Outperform on Flywire, Raises Price Target to $48

Southwest Air Shares Quiet Following Info From Air Flight Tracker, Flightaware, Co. Has 14% Of Flights Cancelled, 15% Delayed

Morgan Stanley Maintains Equal-Weight on Arrowhead Pharmaceuticals, Lowers Price Target to $37